A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples